Berlin - Delayed Quote EUR

AcelRx Pharmaceuticals Inc (R5XA.BE)

Compare
0.4175
-0.0095
(-2.22%)
At close: April 17 at 9:40:05 PM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-12,683
-12,683
-17,492
-28,331
-30,002
Investing Cash Flow
3,781
3,781
-528
36,450
-26,123
Financing Cash Flow
12,044
12,044
3,466
-507
41,514
End Cash Position
8,863
8,863
5,721
20,275
12,663
Interest Paid Supplemental Data
--
--
119
837
1,600
Capital Expenditure
--
--
-100
-364
-1,827
Issuance of Capital Stock
--
--
8,856
8,225
50,278
Repayment of Debt
--
--
-5,416
-8,433
-8,833
Repurchase of Capital Stock
--
--
--
-315
--
Free Cash Flow
-12,683
-12,683
-17,592
-28,695
-31,829
12/31/2021 - 9/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers